Abundnz
Woerden
About Abundnz
Abundnz offers advanced analytical support for biotechnology and diagnostics industries and life science research worldwide. Based on well-established or customized analytical solutions addressing highly specific demands, they deliver comprehensive services which contribute significantly to successful innovative drug development. With the use of mass spectrometry, they characterize innovative medicines like peptide and protein drugs, oligonucleotides and targeted drug delivery systems and they discover and validate biomarkers. Abundnz has a unique technology to determine the clearance profile of innovative medicines in an early phase of drug development. Benefits are a reduction of costs, a faster time-to-market and a safer testing of bipharmaceuticals.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $60.2K
- Last round: Grant (Jan 2015)
- Website: abundnz.com
- Phone: +31 6 539 78 750
Industries & Categories
Biopharma, Biotechnology, Health Care
Social Profiles
Canonical: https://fsome.com/organization/abundnz-3732680 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.